See more : Heron Therapeutics, Inc. (0J4V.L) Income Statement Analysis – Financial Results
Complete financial analysis of Vineet Laboratories Limited (VINEETLAB.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vineet Laboratories Limited, a leading company in the Chemicals industry within the Basic Materials sector.
You may be interested
- Tantalex Lithium Resources Corp. (TTLXF) Income Statement Analysis – Financial Results
- YM Tech Co., Ltd. (273640.KQ) Income Statement Analysis – Financial Results
- Carnival Corporation & plc (CCL.L) Income Statement Analysis – Financial Results
- V-Guard Industries Limited (VGUARD.NS) Income Statement Analysis – Financial Results
- Ying Han Technology Co., Ltd. (4562.TW) Income Statement Analysis – Financial Results
Vineet Laboratories Limited (VINEETLAB.NS)
About Vineet Laboratories Limited
Vineet Laboratories Limited engages in the research, development, and manufacture of active pharmaceutical ingredients and fine chemicals in India. The company was incorporated in 2016 and is based in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.51B | 2.12B | 1.91B | 2.43B | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 1.37B | 1.72B | 1.46B | 2.02B | 20.75K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 139.85M | 399.65M | 454.26M | 413.98M | -20.75K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 9.29% | 18.83% | 23.76% | 17.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 9.64M | 14.92M | 9.75M | 4.14M | 41.89K | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 25.26M | 25.49M | 750.00K | 330.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 34.89M | 40.41M | 10.50M | 4.47M | 41.89K | 0.00 | 0.00 | 0.00 |
| Other Expenses | 58.14M | 1.23M | 313.00K | 653.00K | -2.36K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 93.03M | 346.78M | 341.97M | 350.59M | 111.02K | 0.00 | 0.00 | 0.00 |
| Cost & Expenses | 1.46B | 2.07B | 1.80B | 2.37B | 111.02K | 0.00 | 0.00 | 0.00 |
| Interest Income | 354.00K | 1.23M | 1.62M | 462.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 47.81M | 33.80M | 20.99M | 20.55M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 25.19M | 23.73M | 20.16M | 18.07M | 111.02K | 161.14K | 52.52K | 22.82K |
| EBITDA | 67.32M | 77.83M | 134.47M | 85.32M | -111.02K | 0.00 | 0.00 | 0.00 |
| EBITDA Ratio | 4.47% | 3.67% | 7.04% | 3.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 46.81M | 54.10M | 112.29M | 61.14M | -111.02K | 0.00 | 0.00 | 0.00 |
| Operating Income Ratio | 3.11% | 2.55% | 5.87% | 2.51% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -43.18M | -35.94M | -18.01M | -22.92M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 3.63M | 20.30M | 93.46M | 40.58M | -111.02K | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.24% | 0.96% | 4.89% | 1.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -6.64M | 7.77M | 27.07M | 22.78M | -111.02K | 0.00 | 0.00 | 0.00 |
| Net Income | 10.27M | 12.53M | 66.39M | 17.80M | -111.02K | 0.00 | 0.00 | 0.00 |
| Net Income Ratio | 0.68% | 0.59% | 3.47% | 0.73% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 1.11 | 1.36 | 7.20 | 1.93 | -0.27 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 1.11 | 1.36 | 7.20 | 1.93 | -0.27 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 9.25M | 9.22M | 9.22M | 9.22M | 410.00K | 9.22M | 9.22M | 9.22M |
| Weighted Avg Shares Out (Dil) | 9.25M | 9.22M | 9.22M | 9.22M | 410.00K | 9.22M | 9.22M | 9.22M |
No news found for: VINEETLAB.NS
Source: https://incomestatements.info
Category: Stock Reports